Douglas Leedy
Impact in
- Nephrology top 10%
- Parathyroid Disorders and Treatments
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 7
- Heart Failure Treatment and Management 2
- Cardiac Valve Diseases and Treatments 2
-
- Cardiac Imaging and Diagnostics 4
- Co-authors
- Richard K. Cheng (12 shared papers)Alexi Vasbinder (6 shared papers)Wayne C. Levy (4 shared papers)Mathew S. Maurer (2 shared papers)Sofia Carolina Masri (1 shared paper)Logan Vincent (1 shared paper)Sergio Teruya (1 shared paper)Jeffeny De Los Santos (1 shared paper)
- Journals
- JACC CardioOncology (2 papers)Heart (2 papers)Current Oncology Reports (1 paper)International Journal of Cardiology (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Douglas Leedy
10 papers receiving 226 citations
Peers
Comparison fields: 5 of 42
- Nephrology 57
- Cardiology and Cardiovascular Medicine 112
- Oncology 78
- Molecular Biology 124
- Cancer Research 20
Countries citing papers authored by Douglas Leedy
This map shows the geographic impact of Douglas Leedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Leedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Leedy more than expected).
Fields of papers citing papers by Douglas Leedy
This network shows the impact of papers produced by Douglas Leedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Leedy. The network helps show where Douglas Leedy may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Leedy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2019 | 50 | |
| 3 | 2021 | 42 | |
| 4 | 2021 | 34 | |
| 5 | 2021 | 29 | |
| 6 | 2019 | 4 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 0 | |
| 12 | 2025 | 0 |
About Douglas Leedy
Douglas Leedy is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology and Surgery, having authored 12 papers that have together received 237 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Cardiac Imaging and Diagnostics (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Heart Failure Treatment and Management (2 papers), Parathyroid Disorders and Treatments (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Cardiac Valve Diseases and Treatments (2 papers) and Coronary Interventions and Diagnostics (1 paper). The work is most often cited by research in Nephrology (57 citations), Cardiology and Cardiovascular Medicine (112 citations), Oncology (78 citations), Molecular Biology (124 citations) and Cancer Research (20 citations). Douglas Leedy has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Richard K. Cheng, Alexi Vasbinder, Wayne C. Levy, Mathew S. Maurer, Sofia Carolina Masri, Logan Vincent, Sergio Teruya, Jeffeny De Los Santos, Parag Goyal and Jan M. Griffin. Their work appears in journals such as JACC CardioOncology, Heart, Current Oncology Reports, International Journal of Cardiology and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.